|
Ralf Heinrich Adams (born 1966) is a biochemist and cell biologist. He is director at the Max-Planck-Institute for Molecular Biomedicine and head of the department Tissue Morphogenesis in Münster, Germany.〔(【引用サイトリンク】url=http://www.mpi-muenster.mpg.de/en/research/teams/adams/index.html )〕 ==Biography== In the year 1996 Adams obtained a PhD in Biochemistry for his work at the Max-Planck-Institute for Brain Research in Frankfurt (Germany), which includes the discovery of several novel semaphorin family molecules and the characterization of their role in axon guidance. As a postdoctoral research fellow with Dr R. Klein at the European Molecular Biology Laboratory in Heidelberg during the years 1996 to 2000, he was among the first to discover that ephrin-B2, a ligand for Eph receptor tyrosine kinases, is a marker for arterial endothelial cells and an important regulator of blood vessel morphogenesis in the developing embryo. Together with his collaborator Dr A. Nebrada, he also demonstrated that the p38α mitogen-activated protein kinase is required for the formation of the vascular network inside the placenta. In 2000 Adams became head of the Vascular Development Laboratory at the Cancer Research UK London Research Institute (formerly, Imperial Cancer Research Fund) and Honorary Senior Research Fellow at the University College London. Since 2007 Adams is Professor for ‘Vascular Biology’ at the Westfälische Wilhelms University and Director at the MPI for Molecular Biomedicine in Münster, Germany. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Ralf Adams」の詳細全文を読む スポンサード リンク
|